Horizon

Lipoprotein-A Study

Main objective:

In this study, an investigational medicine is taken at regular intervals in order to determine injected efficacy in reducing lipoprotein-a levels and major cardiovascular events.

Who are we looking for?

  • Age 18-80
  • Currently taking a cholesterol lowering agent
  • History of:
    • Stroke
    • Myocardial Infarction
    • Peripheral vascular disease
  • Additional Criteria not listed

What’s provided for duration of study:

  • Study medication
  • Safety tests
  • Modest compensation for each visit completed
CONTACT US

If you would like additional information, please send us an email or give us a call!

334-504-7020
volunteerinfo@secclinicalresearch.com

Thank you for your interest – we look forward to hearing from you!

Facebook

© 2023 SEC CLINICAL RESEARCH - ALL RIGHTS RESERVED